X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 800 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 326-350 of 800 matching filings.

Per page
25
Current page
14
4

FORM 4

Filing date
19 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Aug 2022
Reporting date
17 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38295

DEF 14A

Filing date
11 Aug 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-266410

EFFECT filing

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-266410

424B3

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
02 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38295

PRE 14A

Filing date
01 Aug 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-266410

S-3

Filing date
29 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-264459

424B3

Filing date
29 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90199

GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Filing date
19 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-452949

D filing

Filing date
19 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jun 2022
Reporting date
06 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .